Dianthus Therapeutics Inc (DNTH)

Jul 27, 2026

Dianthus Therapeutics, Inc. $DNTH Shares Bought by SummitTX Capital L.P. - MarketBeat

Jul 27, 2026

Jul 27, 2026

Octagon Capital Advisors LP Has $163.36 Million Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Jul 27, 2026

Jul 27, 2026

Dianthus Therapeutics Inc (DNTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 27, 2026

Dianthus Therapeutics Inc (DNTH) Cash Flow - TradingKey

Jul 27, 2026

Jul 26, 2026

Dianthus Therapeutics Inc (DNTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026

Jul 26, 2026

Dianthus Therapeutics, Inc. Revenue Breakdown – NASDAQ:DNTH - TradingView

Jul 26, 2026

Jul 25, 2026

Dianthus Therapeutics, Inc. Revenue Breakdown – BOATS:DNTH - TradingView

Jul 25, 2026

Jul 25, 2026

Spruce Street Capital LP Raises Stock Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Jul 25, 2026

Jul 25, 2026

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jul 25, 2026

Jul 24, 2026

DNTH|Dianthus Therapeutics Inc|Price:103.870|Chg%:-0.920 - TradingKey

Jul 24, 2026

Jul 23, 2026

Walleye Capital LLC Has $12.89 Million Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Jul 23, 2026

Jul 21, 2026

Jennison Associates LLC Buys New Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Jul 21, 2026

Jul 21, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Sets New 52-Week HighTime to Buy? - MarketBeat

Jul 21, 2026

Jul 20, 2026

Dianthus Therapeutics Inc. Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Operational DisciplineProfit Announcement - dars.gov.et

Jul 20, 2026

Jul 20, 2026

Wedbush Maintains Dianthus Therapeutics (DNTH) Outperform Recommendation - MSN

Jul 20, 2026

Jul 20, 2026

Dianthus Therapeutics Stock Surges After Initiating Major Phase 3 Clinical Trial - TIKR.com

Jul 20, 2026

Jul 20, 2026

Enterprise value to EBITDA forward of Dianthus Therapeutics, Inc. – FWB:87E - TradingView

Jul 20, 2026

Jul 17, 2026

Dianthus Therapeutics, Inc. (DNTH) reports Q1 loss, lags revenue estimates - MSN

Jul 17, 2026

Jul 17, 2026

Dianthus Therapeutics DNTH Jumps As Phase 3 EMERGE Trial Kicks Off - timothysykes.com

Jul 17, 2026

Jul 17, 2026

DNTH Stock Pops As Phase 3 EMERGE Trial Kicks Off - StocksToTrade

Jul 17, 2026

Jul 17, 2026

Dianthus Therapeutics stock hits 52-week high at 102.38 USD By Investing.com - Investing.com Nigeria

Jul 17, 2026

Jul 17, 2026

Dianthus Therapeutics stock hits 52-week high at 102.38 USD - Investing.com India

Jul 17, 2026

Jul 17, 2026

Dianthus Therapeutics Rockets As Phase 3 Hype Builds - TipRanks

Jul 17, 2026

Jul 13, 2026

Form 4 Dianthus Therapeutics Inc For: 13 July By Investing.com - Investing.com Nigeria

Jul 13, 2026

Jul 13, 2026

Dianthus therapeutics CFO Ryan Savitz sells $3.16 million in shares By Investing.com - Investing.com Australia

Jul 13, 2026

Jul 13, 2026

Dianthus therapeutics CFO Ryan Savitz sells $3.16 million in shares - Investing.com

Jul 13, 2026

Jul 13, 2026

Dianthus Therapeutics (DNTH) CFO sells 31,249 shares in 10b5-1 trades - Stock Titan

Jul 13, 2026

Jul 10, 2026

Dianthus Therapeutics (DNTH) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentMid-Term Outlook - Bölüm Sonu Canavarı

Jul 10, 2026

Jul 10, 2026

Dianthus Therapeutics (DNTH) Starts Phase 3 EMERGE Trial, Is The Upside Already Priced In? - Sahm

Jul 10, 2026

Jul 09, 2026

Form 144 Dianthus Therapeutics For: 9 July By Investing.com - Investing.com South Africa

Jul 09, 2026

Jul 09, 2026

[144] Dianthus Therapeutics, Inc. /DE/ SEC Filing - Stock Titan

Jul 09, 2026

Jul 09, 2026

Dianthus Therapeutics stock hits 52-week high at 99.36 USD By Investing.com - Investing.com Nigeria

Jul 09, 2026

Jul 09, 2026

Dianthus Therapeutics stock hits 52-week high at 99.36 USD - Investing.com

Jul 09, 2026

Jul 08, 2026

Dianthus Advances Claseprubart Into Phase 3 EMERGE Trial, Raising Stakes in the Myasthenia Gravis Market - TipRanks

Jul 08, 2026

Jul 08, 2026

Price to earnings forward of Dianthus Therapeutics, Inc. – MUN:87E - TradingView

Jul 08, 2026

Jul 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 07, 2026

Jul 05, 2026

Enterprise value to revenue forward of Dianthus Therapeutics, Inc. – NASDAQ:DNTH - TradingView

Jul 05, 2026

Jul 05, 2026

DNTHDianthus Therapeutics Inc Revenue Breakdown - Finviz

Jul 05, 2026

Jul 03, 2026

Dianthus Therapeutics Inc. Q1 2026 Earnings: EPS Surprise of 22.28% Drives Positive Stock ReactionRevenue Per Share - dars.gov.et

Jul 03, 2026

Jul 02, 2026

DNTH News | DIANTHUS THERAPEUTICS INC (NASDAQ:DNTH) - ChartMill

Jul 02, 2026

Jul 02, 2026

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Jul 02, 2026

Jul 02, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants - Yahoo Finance

Jul 02, 2026

Jul 01, 2026

Price to book forward of Dianthus Therapeutics, Inc. – NASDAQ:DNTH - TradingView

Jul 01, 2026

Jun 30, 2026

DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch - Stocktwits

Jun 30, 2026

Jun 30, 2026

Why Dianthus Therapeutics (DNTH) Is Up 11.4% After Launching Its Phase 3 EMERGE gMG Trial - Sahm

Jun 30, 2026

Jun 29, 2026

Dianthus Therapeutics stock hits 52-week high at 96.85 USD By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Dianthus Therapeutics, Inc.(NasdaqCM:DNTH) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Dianthus Therapeutics, Inc.(NasdaqCM:DNTH) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026